other
confidence high
sentiment neutral
materiality 0.35
ELITE PHARMACEUTICALS INC /NV/ (ELTP): auditor change — Elite Pharmaceuticals dismisses Buchbinder, appoints Mazers as new auditor
ELITE PHARMACEUTICALS INC /NV/
- Audit Committee approved appointment of Mazers USA LLP on July 11, 2023, effective same day.
- Buchbinder Tunick & Company LLP was dismissed as independent auditor, effective July 12, 2023.
- No disagreements or reportable events with Buchbinder during fiscal years 2022 and 2023 or subsequent interim period.
- Buchbinder's reports for those fiscal years contained no adverse opinion or qualification.